Ignite Creation Date:
2024-05-05 @ 10:23 AM
Last Modification Date:
2024-10-26 @ 9:01 AM
Study NCT ID:
NCT00000178
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-10-29
Brief Title:
Multicenter Trial of Prednisone in Alzheimers Disease
Sponsor:
National Institute on Aging NIA
Organization:
National Institute on Aging NIA
Study Overview
Official Title:
Multicenter Trial of Prednisone in Alzheimers Disease
Status:
COMPLETED
Status Verified Date:
2005-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a randomized placebo controlled double blind study Patients who meet eligibility criteria and decide to participate in the study will be randomly assigned to receive either drug treatment or a placebo Neither the patients nor the participating investigators will know who is receiving the drugs and who is receiving the placebo Participation involves 15 outpatient clinic visits over a 68 week period Patients take study medication at varying doses the maximum dose is 20 mg daily along with calcium and vitamin supplements
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 3U01AG010483-08S2 | NIH | None | httpsreporternihgovquickSearch3U01AG010483-08S2 |